Chapter 4 Alzheimer's Disease in Adults with Down Syndrome
- 1 January 2008
- book chapter
- Published by Elsevier
- Vol. 36, 103-145
Abstract
No abstract availableKeywords
This publication has 154 references indexed in Scilit:
- The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndromeActa Neuropathologica, 2008
- Significant effect of APOE epsilon 4 genotype on the risk of dementia in Alzheimer's disease and mortality in persons with Down SyndromeInternational Journal of Geriatric Psychiatry, 2008
- Disruptive Behavior as a Predictor in Alzheimer DiseaseArchives of Neurology, 2007
- Association between genetic variants in sortilin-related receptor 1 (SORL1) and Alzheimer's disease in adults with Down syndromeNeuroscience Letters, 2007
- Elevated Plasma β-Amyloid Peptide Aβ42 Levels, Incident Dementia, and Mortality in Down SyndromeArchives of Neurology, 2007
- Cholesterol level, statin use and Alzheimer's disease in adults with Down syndromeNeuroscience Letters, 2007
- Intraneuronal Aβ immunoreactivity is not a predictor of brain amyloidosis-β or neurofibrillary degenerationActa Neuropathologica, 2007
- The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer diseaseNature Genetics, 2007
- Telomere shortening in T lymphocytes of older individuals with Down syndrome and dementiaNeurobiology of Aging, 2006
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993